Inhibition of hepatic tumor cell proliferation in vitro and tumor growth in vivo by taltobulin, a synthetic analogue of the tripeptide hemiasterlin

Figure 2 Effect of HTI-286 on primary human hepatocytes. Human hepatocytes were exposed to HTI-286 for 24 and 48 h at concentrations between 1 nmol/L and 1 mmol/L. No significant decrease in viable cells was detected in MTT assay at any concentration.